annual current liabilities:
$230.10M+$91.25M(+65.72%)Summary
- As of today (May 30, 2025), AXSM annual total current liabilities is $230.10 million, with the most recent change of +$91.25 million (+65.72%) on December 31, 2024.
- During the last 3 years, AXSM annual current liabilities has risen by +$207.04 million (+897.62%).
- AXSM annual current liabilities is now at all-time high.
Performance
AXSM Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$243.91M+$13.81M(+6.00%)Summary
- As of today (May 30, 2025), AXSM quarterly total current liabilities is $243.91 million, with the most recent change of +$13.81 million (+6.00%) on March 31, 2025.
- Over the past year, AXSM quarterly current liabilities has increased by +$99.87 million (+69.33%).
- AXSM quarterly current liabilities is now at all-time high.
Performance
AXSM quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
AXSM Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +65.7% | +69.3% |
| 3 y3 years | +897.6% | +893.6% |
| 5 y5 years | +839.4% | +834.5% |
AXSM Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +897.6% | at high | +893.6% |
| 5 y | 5-year | at high | +897.6% | at high | +1099.1% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
AXSM Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $243.91M(+6.0%) |
| Dec 2024 | $230.10M(+65.7%) | $230.10M(+17.3%) |
| Sep 2024 | - | $196.19M(+5.2%) |
| Jun 2024 | - | $186.57M(+29.5%) |
| Mar 2024 | - | $144.05M(+3.7%) |
| Dec 2023 | $138.85M(+43.8%) | $138.85M(+21.1%) |
| Sep 2023 | - | $114.66M(-0.3%) |
| Jun 2023 | - | $114.97M(+14.2%) |
| Mar 2023 | - | $100.65M(+4.2%) |
| Dec 2022 | $96.56M(+318.6%) | $96.56M(+60.2%) |
| Sep 2022 | - | $60.28M(+41.6%) |
| Jun 2022 | - | $42.57M(+73.4%) |
| Mar 2022 | - | $24.55M(+6.4%) |
| Dec 2021 | $23.07M(-1.6%) | $23.07M(-6.6%) |
| Sep 2021 | - | $24.71M(+8.1%) |
| Jun 2021 | - | $22.86M(+5.4%) |
| Mar 2021 | - | $21.68M(-7.5%) |
| Dec 2020 | $23.44M(-4.3%) | $23.44M(+15.2%) |
| Sep 2020 | - | $20.34M(-11.6%) |
| Jun 2020 | - | $23.00M(-11.9%) |
| Mar 2020 | - | $26.10M(+6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $24.49M(+126.3%) | $24.49M(+32.3%) |
| Sep 2019 | - | $18.51M(+41.6%) |
| Jun 2019 | - | $13.07M(+69.5%) |
| Mar 2019 | - | $7.71M(-28.8%) |
| Dec 2018 | $10.82M(-11.1%) | $10.82M(-1.1%) |
| Sep 2018 | - | $10.94M(+14.9%) |
| Jun 2018 | - | $9.53M(+1.1%) |
| Mar 2018 | - | $9.42M(-22.6%) |
| Dec 2017 | $12.18M(+69.8%) | $12.18M(+44.9%) |
| Sep 2017 | - | $8.40M(+2.3%) |
| Jun 2017 | - | $8.21M(-1.7%) |
| Mar 2017 | - | $8.36M(+16.5%) |
| Dec 2016 | $7.17M(+172.5%) | $7.17M(+6.5%) |
| Sep 2016 | - | $6.74M(+32.0%) |
| Jun 2016 | - | $5.10M(+30.4%) |
| Mar 2016 | - | $3.91M(+48.7%) |
| Dec 2015 | $2.63M(+170.6%) | $2.63M(+17.8%) |
| Sep 2015 | - | $2.23M(+46.1%) |
| Jun 2015 | - | $1.53M(+57.3%) |
| Dec 2014 | $972.60K(-76.4%) | $972.60K |
| Dec 2013 | $4.13M | - |
FAQ
- What is Axsome Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Axsome Therapeutics?
- What is Axsome Therapeutics annual current liabilities year-on-year change?
- What is Axsome Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly current liabilities year-on-year change?
What is Axsome Therapeutics annual total current liabilities?
The current annual current liabilities of AXSM is $230.10M
What is the all time high annual current liabilities for Axsome Therapeutics?
Axsome Therapeutics all-time high annual total current liabilities is $230.10M
What is Axsome Therapeutics annual current liabilities year-on-year change?
Over the past year, AXSM annual total current liabilities has changed by +$91.25M (+65.72%)
What is Axsome Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of AXSM is $243.91M
What is the all time high quarterly current liabilities for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly total current liabilities is $243.91M
What is Axsome Therapeutics quarterly current liabilities year-on-year change?
Over the past year, AXSM quarterly total current liabilities has changed by +$99.87M (+69.33%)